|Articles|January 21, 2022
Orphan Drug Development – A pragmatic approach to developing a rare disease drug
Author(s)Curia (formerly AMRI)
Related Content
- News
- Multimedia
- Webcasts
- Resources
- Event Calendar
- Subscribe
- Analytics
- Data and Artificial Intelligence
- Dosage Forms
- Drug Development
- Manufacturing
- Aseptic/Sterile Processing
- Equipment
- Process and Automation
- Manufacturing, Parenterals and Injectables
- Manufacturing, Biosimilars and Biobetters
- Manufacturing, Inhalation Drugs
- Manufacturing, Solid and Semi-Solid Dosage Drugs
- Manufacturing, Cell Therapies
- Manufacturing, Biologic Drugs
- Supply Chain
- Manufacturing, Gene Therapies
- Packaging and Distribution
- Outsourcing
- Quality Systems